[Congressional Record Volume 171, Number 100 (Wednesday, June 11, 2025)]
[Extensions of Remarks]
[Page E561]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




          INTRODUCTION OF MEDICAL RESEARCH FOR OUR TROOPS ACT

                                 ______
                                 

                            HON. STEVE COHEN

                              of tennessee

                    in the house of representatives

                        Wednesday, June 11, 2025

  Mr. CARSON. Mr. Speaker, I am proud to introduce the Medical Research 
for Our Troops Act, a bill to amend the Full-Year Continuing 
Appropriations and Extensions Act, 2025, by restoring essential funding 
for Congressionally Directed Medical Research Programs within the 
Department of Defense Account. I thank my colleague, Rep. Mike Levin 
for joining me as a co-lead of this important legislation, the 21 
original cosponsors who support the bill, and the 66 organizations who 
endorse the bill text.
  Congressionally Directed Medical Research Programs have been 
instrumental in advancing groundbreaking medical research that directly 
benefit our service members and veterans. Over the years, this program 
has supported lifesaving innovations in areas such as traumatic brain 
injury. PTSD, breast cancer, and other conditions that 
disproportionately affect our military community. Many treatments and 
therapies that were once experimental are now standard care, thanks to 
the success and dedication of Congressionally Directed Medical Research 
Programs-funded research.
  Our bill restores funding to levels aligned with the Consolidated 
Appropriations Act, 2024, ensuring continuity of these vital research 
efforts. By doing so, we reaffirm our commitment to sustaining the 
momentum of these proven programs that save lives and improve the 
health outcomes of those who serve our Nation.
  I urge my colleagues to support this legislation to ensure that 
medical research for our troops and veterans remains strong, 
innovative, and fully funded.

                          ____________________